SCHEMBL3608762

SCHEMBL3608762

OC1CCN(c2cnc(Cl)cn2)CC1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMO Q99835 2/20 0.47
PTPN11 Q06124 1/20 0.45
PANK3 Q9H999 1/20 0.42
ACKR3 P25106 1/20 0.39
SMPD3 Q9NY59 2/20 0.39
OGA O60502 1/20 0.39
CCNT1 O60563 1/20 0.38
MAPT P10636 1/20 0.38
MCHR1 Q99705 1/20 0.37
LMNA P02545 2/20 0.36
HTT P42858 2/20 0.36
HTR3E A5X5Y0 1/20 0.36
MEN1 O00255 1/20 0.36
HTR3B O95264 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP2D6 P10635 1/20 0.36
ALOX15 P16050 1/20 0.36
TSHR P16473 1/20 0.36
NFKB1 P19838 1/20 0.36
HTR3A P46098 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12524364 0.81 CHRM4 (0.39) PANK3OGAMCHR1CHRNB2CHRNB4
SCHEMBL20070056 0.80 SMPD3 (0.44) PANK3SMPD3
SCHEMBL20148211 0.80 SMO (0.45) SMOPTPN11ACKR3SMPD3CCNT1
SCHEMBL988306 0.80 KCNH2 (0.50) SMOPTPN11ACKR3SMPD3MAPT
SCHEMBL19439057 0.79 MAPT (0.44) SMOPTPN11PANK3OGAMAPT
SCHEMBL29504721 0.79 PANK3 (0.46) SMOPTPN11PANK3OGAKDM4E
SCHEMBL19434903 0.79 PANK3 (0.46) SMOPTPN11PANK3OGAKDM4E
SCHEMBL23408629 0.79 CYP1A2 (0.47) PANK3OGAMAPTLMNACYP1A2
SCHEMBL29596859 0.77 CHRM4 (0.37) PANK3OGACHRNB2CHRNB4CHRNA3
SCHEMBL24624329 0.77 CHRM4 (0.37) PANK3OGACHRNB2CHRNB4CHRNA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100004245-A1 AZACYCLOALKANE DERIVATIVES AS INHIBITORS OF STEAROYL-COENZYME A DELTA-9 DESATURASE MERCK FROSST CANADA LTD. (CA) 2010-01-07 US disclosed
EP-2076509-A1 AZACYCLOALKANE DERIVATIVES AS INHIBITORS OF STEAROYL-COENZYME A DELTA-9 DESATURASE Merck Frosst Canada Ltd. (CA) 2009-07-08 EP disclosed
WO-2008046226-A1 AZACYCLOALKANE DERIVATIVES AS INHIBITORS OF STEAROYL-COENZYME A DELTA-9 DESATURASE MERCK FROSST CANADA LTD. (CA) 2008-04-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100004245-A1 AZACYCLOALKANE DERIVATIVES AS INHIBITORS OF STEAROYL-COENZYME A DELTA-9 DESATURASE SCD, SCD5, SREBF1 SMO 746/4885PTPN11 3765/4885PANK3 2155/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.